P
Philip J. Bierman
Researcher at University of Nebraska–Lincoln
Publications - 11
Citations - 519
Philip J. Bierman is an academic researcher from University of Nebraska–Lincoln. The author has contributed to research in topics: Transplantation & Lymphoma. The author has an hindex of 6, co-authored 11 publications receiving 490 citations. Previous affiliations of Philip J. Bierman include University of Nebraska Medical Center.
Papers
More filters
Journal ArticleDOI
Central Nervous System Cancers
Louis B. Nabors,Mario Ammirati,Philip J. Bierman,Henry Brem,Nicholas Butowski,Marc C. Chamberlain,Lisa M. DeAngelis,Robert A. Fenstermaker,Allan H. Friedman,Mark R. Gilbert,Deneen Hesser,Matthias Holdhoff,Larry Junck,Ronald Lawson,Jay S. Loeffler,Moshe H. Maor,Paul L. Moots,Tara Morrison,Maciej M. Mrugala,Herbert B. Newton,Jana Portnow,Jeffrey J. Raizer,Lawrence Recht,Dennis C. Shrieve,Allen K. Sills,David Tran,Nam D. Tran,Frank D. Vrionis,Patrick Y. Wen,Maria Ho +29 more
TL;DR: These guidelines provide recommendations on the diagnosis and management of this group of diseases based on clinical evidence and panel consensus and include expert advice on the management of low-grade infiltrative astrocytomas, oligodendrogliomas, anaplastic gliomas, glioblastomas, medulloblastoma, supratentorial primitive neuroectodermal tumors, and brain metastases.
Journal ArticleDOI
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project
Charles L. Bennett,Andrew M. Evens,Leslie A. Andritsos,Lakshmi Balasubramanian,Mark Mai,Matthew J. Fisher,Timothy M. Kuzel,Cara Angelotta,June M. McKoy,Julie M. Vose,Philip J. Bierman,David J. Kuter,Steven Trifilio,Steven M. Devine,Martin S. Tallman +14 more
TL;DR: While a causal relationship with haematological malignancies cannot be demonstrated, long‐term follow‐up among healthy individuals who receive haem atopoietic growth factors is needed.
Journal ArticleDOI
Correlation of Secondary Cytogenetic Abnormalities With Histologic Appearance in Non-Hodgkin's Lymphomas Bearing t(14;18)(q32;q21)
James O. Armitage,Warren G. Sanger,Dennis D. Weisenburger,D. S. Harrington,James Linder,Philip J. Bierman,Julie M. Vose,D. T. purtilo +7 more
TL;DR: It appears that patients with B-cell non-Hodgkin's lymphomas bearing the t(14;18)(q32;q21) translocation which also have an additional chromosome 7 are likely to exhibit a diffuse growth pattern.
Journal ArticleDOI
Survival Disparities in Patients With Lymphoma According to Place of Residence and Treatment Provider: A Population-Based Study
Fausto R. Loberiza,Anthony J. Cannon,Dennis D. Weisenburger,Julie M. Vose,Matthew J. Moehr,Martin Bast,Philip J. Bierman,R. Gregory Bociek,James O. Armitage +8 more
TL;DR: Survival outcomes of patients with lymphoma may be associated with place of residence and treatment provider, and high-risk patients from rural areas may benefit from better coordination of care.
Journal ArticleDOI
Radioimmunotherapy with 131-I tositumomab enhanced survival in good prognosis relapsed and high-risk diffuse large B-cell lymphoma (DLBCL) patients receiving high-dose chemotherapy and autologous stem cell transplantation
Julie M. Vose,Philip J. Bierman,G. Bociek,F. R. Loberiza,C. Enke,J. Hankins,James O. Armitage +6 more
TL;DR: The addition of standard transplantation for relapsed chemosensitive DLBCL with standard chemotherapy improved survival by up to 50% in patients with relapsed chemotherapy-related relapses.